Breaking News

Tweet TWEET

Dr. Reddy's to Release Q1 FY15 Results on July 30, 2014

  Dr. Reddy's to Release Q1 FY15 Results on July 30, 2014           Earnings call slated for July 30, 6.30 PM IST / 9.00 AM EDT*  Business Wire  HYDERABAD, India -- July 23, 2014  Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First Quarter ended June 30, 2014 on Wednesday, July 30, 2014 after the Board Meeting. The results will be available on the Company’s website www.drreddys.com.  Summary of Events                                                   Event                 Date and Time               Medium Release of financial  July 30th, after the Board  Email, Media, Company results                Meeting                      website, Business Wire                        July 30th, 6.30 PM IST /     Hosted by the Company Earnings Call         9:00 AM EDT                                                                     (Details below) Webcast of Earnings    July 30th, 6.30 PM IST /     URL available on Company’s Call                  9.00 AM EDT through August  website, www.drreddys.com                        4th, 2014 Transcript of the     Will be available on the    URL available on Company’s Earnings call          Company’s website            website, www.drreddys.com                                                    Earnings Call  Following the release, the management of the Company will host an earnings call to discuss the Company’s financial performance.   Conference Dial-In Numbers Primary Number:            +91 22 3960 0616 Secondary Number:          +91 22 6746 5826 The numbers listed above are universally accessible from all networks and all countries.                             6000 1221                             Available in - Ahmedabad, Bangalore, Bhubaneswar,                             Chandigarh, Chennai, Coimbatore, Delhi, Goa,                             Guntur, Gurgaon, Hyderabad, Indore, Jamshedpur,                             Kanpur, Kochi/Cochin, Kolhapur, Kolkata, Nagpur,                             Noida, Patna, Pune, Raipur, Rajkot, Surat,                             Trivandrum, Vadodara, Vijayawada  Local Access Number:       Accessible from all major carriers except                             BSNL/MTNL.                              3940 3977                              Available in Ahmedabad, Bangalore, Chandigarh,                             Chennai, Kochi/Cochin, Gurgaon (NCR), Hyderabad,                             Kolkata, Lucknow, Pune                              Accessible from all carriers.                             USA: 1 866 746 2133  International Toll Free     UK: 0 808 101 1573 Number:                                                Singapore: 800 101 2045                              Hong Kong: 800 964 448                               No password/pin number is necessary to dial in to any of the other calls. As participation in the call is limited, early registration is encouraged. The operator will provide instructions on asking questions before and during the call.  Audio Webcast  The audio webcast of the earnings call will be available to all interested parties at www.drreddys.com. Please visit the web site at least fifteen minutes ahead of the scheduled start time to register and to download and install any necessary audio software. Participants in the webcast can listen to the proceedings, but will not be able to ask questions. The replay will be available 2 hours after the earnings call, through August 4th, 2014. For play back dial in phone No: 022 3065 1212 and ID: 375#.  Transcript  The transcript of the earnings call will also be available on the Company's website.  About Dr. Reddy’s  Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. Through its three businesses - Pharmaceutical Services and Active Ingredients, Global Generics and Proprietary Products – Dr. Reddy’s offers a portfolio of products and services including APIs, custom pharmaceutical services, generics, biosimilars and differentiated formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular, diabetology, oncology, pain management and anti-infective. Major markets include India, USA, Russia-CIS and Europe apart from other select geographies within Emerging Markets.  For more information, log on to: www.drreddys.com  *EDT- Eastern Daylight Saving Time  Contact:  Dr. Reddy's Laboratories Investor Relations: Kedar Upadhye, +91 40 66834297 kedaru@drreddys.com or Saunak Savla, +91 40 49002135 saunaks@drreddys.com or Milan Kalawadia (USA), +1 9082034931 mkalawadia@drreddys.com  
Press spacebar to pause and continue. Press esc to stop.